Ligand validation:4V3D

PTY: PHOSPHATIDYLETHANOLAMINE

PTY is a Ligand Of Interest in 4V3D designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4V3D_PTY_B_200	37%	72%	0.219	0.916	0.46	0.63	-	1	3	0	100%	1
4V3D_PTY_D_200	16%	71%	0.295	0.865	0.49	0.61	-	2	3	0	100%	1
6SNY_PTY_B_200	72%	73%	0.138	0.963	0.47	0.58	-	1	5	0	100%	1
1LQV_PTY_B_607	61%	63%	0.119	0.906	0.85	0.58	3	-	0	0	100%	1
3JTC_PTY_B_607	39%	37%	0.169	0.877	1.1	1.36	4	5	2	0	100%	1
7OKS_PTY_A_201	36%	58%	0.16	0.874	0.62	0.98	1	2	0	0	88%	0.88
1L8J_PTY_A_200	27%	66%	0.151	0.798	0.83	0.49	2	-	6	0	100%	1
4N31_PTY_B_201	39%	44%	0.173	0.917	0.71	1.42	-	3	1	0	78%	0.75
3W5A_PTY_B_1003	38%	22%	0.101	0.915	1.58	1.68	2	2	1	0	38%	0.38
3PG7_PTY_A_400	37%	35%	0.161	0.873	1.27	1.28	3	4	5	0	92%	0.92

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.